Cooke & Bieler LP Purchases 1,794,391 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cooke & Bieler LP lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,172,876 shares of the medical instruments supplier’s stock after purchasing an additional 1,794,391 shares during the period. DENTSPLY SIRONA comprises 1.7% of Cooke & Bieler LP’s investment portfolio, making the stock its 20th largest holding. Cooke & Bieler LP owned approximately 4.61% of DENTSPLY SIRONA worth $174,101,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pacer Advisors Inc. lifted its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after acquiring an additional 1,244,326 shares during the period. Invenomic Capital Management LP acquired a new position in shares of DENTSPLY SIRONA in the third quarter worth approximately $23,724,000. National Bank of Canada FI lifted its stake in shares of DENTSPLY SIRONA by 85.8% in the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock worth $44,059,000 after acquiring an additional 751,800 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in DENTSPLY SIRONA by 50.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock valued at $55,900,000 after buying an additional 692,100 shares during the period. 95.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on XRAY shares. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. UBS Group dropped their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Mizuho started coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Evercore ISI reissued an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, Needham & Company LLC dropped their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $23.58.

DENTSPLY SIRONA Trading Down 1.7 %

Shares of DENTSPLY SIRONA stock opened at $16.05 on Tuesday. The stock has a fifty day simple moving average of $18.54 and a 200 day simple moving average of $21.14. DENTSPLY SIRONA Inc. has a 12-month low of $15.47 and a 12-month high of $34.28. The company has a market capitalization of $3.19 billion, a P/E ratio of -7.75, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.99%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.